Melanoma Genome Sequencing Project

AGE_AT_BIOPSY - Age of patient at biopsy (phv00167385.v5.p2)
AGE_AT_COLLECTION - Age of patient at data collection (phv00529944.v2.p2)
AGE_AT_DIAGNOSIS - Age of patient at diagnosis (phv00167384.v5.p2)
AGE_START_THERAPY - Subject age at start of therapy (phv00529939.v2.p2)
SEX - Sex of the subjects as reported (phv00529938.v2.p2)

% MELANOMA CELLS - % of the cells that are melanoma (phv00167401.v5.p2)
BEST_RESPONSE - Best response via RECIST criteria (phv00529942.v2.p2)
HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00167402.v5.p2)
LOCALIZATION_OF_PRIMARY_MELANOMA - Localization of primary melanoma (phv00543600.v2.p2)
MEDICATION - Drug used at start of therapy (phv00529940.v2.p2)
MELANOMA_PRIMARY_DIAGNOSIS - Primary diagnosis of melanoma (phv00167387.v5.p2)
SUB-LOCALIZATION_OF_PRIMARY_MELANOMA - Sub-localization of primary melanoma (phv00543601.v2.p2)
SYSTEMIC_THERAPY - Systemic therapy for patient (phv00167394.v5.p2)
TUMOR_STAGE_AT_TIME_OF_PRIMARY - Tumor stage at time of primary (phv00543602.v2.p2)
TUMOR_TYPE - Type of tumor (i.e. primary, metastatic, recurrent) (phv00167399.v5.p2)

ANALYTE_TYPE - Analyte Type (phv00167397.v5.p2)
BODY_SITE - Body site where sample was collected (phv00167400.v5.p2)
CONSENT - Consent group as determined by DAC (phv00167374.v5.p2)
DURATION_THERAPY_WEEKS - Duration therapy was administered in weeks (phv00529941.v2.p2)
IS_TUMOR - Delineates if sample is tumor or normal (phv00167396.v5.p2)
NORMAL_SAMPLE_SOURCE - Biopsy source of normal DNA sequenced (phv00543599.v2.p2)
ORIGINAL_MATERIAL_TYPE - Material (i.e. blood, tissue) that the data is derived from (phv00167398.v5.p2)
PRIMARY_DISEASE - Primary disease of patient (phv00167386.v5.p2)
SAMPLE_ID - Sample ID (phv00167395.v5.p2)
SAMPLE_ID - Sample ID (phv00167378.v5.p2)
SUBJECT_ID - Subject ID (phv00167382.v5.p2)
SUBJECT_ID - Subject ID (phv00167373.v5.p2)
SUBJECT_ID - Subject ID (phv00167377.v5.p2)